Impact of sodium –glucose cotransporter 2 inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease with normoalbuminuria

We compared the effects of sodium –glucose cotransporter 2 (SGLT2) inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease (CKD) classified by degree of albuminuria.

Source: Diabetology and Metabolic Syndrome - January 10, 2020 Category: Endocrinology Authors: Akinobu Nakamura, Hideaki Miyoshi, Hiraku Kameda, Kumiko Yamashita and Yoshio Kurihara Tags: Short report Source Type: research